Investigating the Optimal Management of Dolutegravir Resistance
- Status
- RECRUITING
- Phase
- N/A
Clinical Trials Related to HIV-1-infection
Related studies linked through entity extraction aliases.
Evaluation of Long-Acting Lenacapavir for the Treatment of HIV-1 in Treatment-experienced Adolescents and Children
- Status
- RECRUITING
- Phase
- PHASE2
Ndovu RCT: Investing the Optimal Management of Dolutegravir Resistance
- Status
- RECRUITING
- Phase
- PHASE3
Caspofungin for Pneumocystis Pneumonia in PLWHIV.
- Status
- RECRUITING
- Phase
- N/A
Primary and Secondary Drug Resistance Mutations (DRMs) in HIV As a Risk Factor of Failure of ART, Including Two Drugs Based Regimens.
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
Acceptance and Commitment Therapy for HIV+ Hazardous Drinkers
- Status
- RECRUITING
- Phase
- NA
Identification of Barriers and Facilitators of Implementation of the Out-of-Hospital Administration of the Long- Acting Combination Cabotegravir+Rilpivirina.
- Status
- COMPLETED
- Phase
- NA
Administration of High Doses of Antiretroviral Drugs to Eliminate the Latent HIV-1 Reservoir
- Status
- RECRUITING
- Phase
- PHASE2
PrEPsmart 2-1-1 Pilot
- Status
- RECRUITING
- Phase
- PHASE2
Study to Compare an Oral Weekly Islatravir/Lenacapavir Regimen With Standard of Care in Virologically Suppressed People With HIV-1
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Study to Compare an Oral Weekly Islatravir/Lenacapavir Regimen With Bictegravir/Emtricitabine/Tenofovir Alafenamide in Virologically Suppressed People With HIV-1
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Study of Oral Weekly GS-1720 and GS-4182 Compared With Biktarvy in People With HIV-1 Who Have Not Been Treated
- Status
- TERMINATED
- Phase
- PHASE2/PHASE3
Analytical Treatment Interruption in a Patient With HIV Post Allogeneic Stem Cell Transplantation From a CCR5 delta32 Homozygous Donor
- Status
- NOT_YET_RECRUITING
- Phase
- NA
Evaluation of Switch to Dolutegravir/Lamivudine (DTG/3TC) From Current Suppressive Antiretroviral Therapy in People Living With HIV (PLWH) Receiving Opioid Agonist Therapy (OAT)
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE4
Tesamorelin as an Adjunct to Exercise for Improving Physical Function in HIV
- Status
- RECRUITING
- Phase
- PHASE2
Study of Oral Weekly Lepetegravir (Formerly GS-1720) and Lenacapavir Pacfosacil (Formerly GS-4182) Versus Biktarvy in People With HIV-1 Who Are Virologically Suppressed
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2/PHASE3
Study of Bictegravir/Lenacapavir in Children and Adolescents With HIV-1
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2/PHASE3
Outcomes of the PLHIV With Suboptimal Viral Suppression to Injectable Long-acting Antiretrovirals
- Status
- RECRUITING
- Phase
- PHASE3
Triage Survey for Infectious Disease Eligibility
- Status
- RECRUITING
- Phase
- N/A
B/F/TAF to DTG/3TC Switch Study
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3